| Record ID | marc_columbia/Columbia-extract-20221130-008.mrc:484729159:2140 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-008.mrc:484729159:2140?format=raw |
LEADER: 02140cam a2200469 a 4500
001 3934708
005 20221027003511.0
008 880719s1988 nyua b 101 0 eng d
010 $a 87022436
020 $a0879692294
035 $a(OCoLC)16468491
035 $a(OCoLC)ocm16468491
035 $a(CStRLIN)NYCM88-B2762
035 $9ADJ7667HS
035 $a(NNC)3934708
035 $a3934708
040 $aDNLM/DLC$cDLC$dCSt$dNNC-M
050 00 $aRM666.P415$bT48 1988
060 0 $aW3 BA19 v. 29$aQU 68 T398 1987
082 0 $a615/.3$219
245 00 $aTherapeutic peptides and proteins :$bassessing the new technologies /$cedited by Daniel R. Marshak, Darrell T. Liu.
260 $aCold Spring Harbor, N.Y. :$bCold Spring Harbor Laboratory,$c1988.
300 $axv, 347 pages :$billustrations ;$c24 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aBanbury report,$x0198-0068 ;$v29
500 $aBased on a conference held Apr. 12-15, 1987, sponsored by Abbott Laboratories and others.
504 $aIncludes bibliographies and indexes.
500 $aTables.
650 0 $aPeptides$xTherapeutic use$xTesting$vCongresses.
650 0 $aProteins$xTherapeutic use$xTesting$vCongresses.
650 0 $aPeptides$xBiotechnology$vCongresses.$0http://id.loc.gov/authorities/subjects/sh2010002898
650 0 $aProteins$xBiotechnology$vCongresses.$0http://id.loc.gov/authorities/subjects/sh2010002925
650 2 $aClinical Trials as Topic.$0https://id.nlm.nih.gov/mesh/D002986
650 2 $aPeptides$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D010455Q000627
650 2 $aProteins$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D011506Q000627
655 2 $aCongress.$0https://id.nlm.nih.gov/mesh/D016423
700 1 $aMarshak, Daniel R.$0http://id.loc.gov/authorities/names/n87894783
700 1 $aLiu, Teh-Yung,$d1932-$0http://id.loc.gov/authorities/names/n80042664
710 2 $aAbbott Laboratories.$0http://id.loc.gov/authorities/names/n50057199
830 0 $aBanbury report ;$v29.$0http://id.loc.gov/authorities/names/n42003120
852 00 $boff,hsl$hRM666.P415$iT48 1988